| Serial Number | 97010825 |
| Word Mark | CREFTESA |
| Filing Date | Friday, September 3, 2021 |
| Status | 731 - SECOND EXTENSION - GRANTED |
| Status Date | Tuesday, February 27, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, January 17, 2023 |
| Goods and Services | pharmaceutical preparations for human use for treatment of Huntington's Disease, chorea associated with Huntington's Disease, schizophrenia, adjunctive treatment of schizophrenia, cognitive impairment associated with schizophrenia, epilepsy, epileptic encephalopathy with continuous spike-and-wave during sleep, SCN8A-related epilepsy with encephalopathy, focal onset seizures, tardive dyskinesia, Parkinson's Disease, adjunctive treatment of Parkinson's Disease, Major Depressive Disorder, anhedonia in Major Depressive Disorder, inadequate response to treatment in Major Depressive Disorder, dyskinetic cerebral palsy, and neuro-immunological and neuro-endocrinological diseases, disorders, and conditions; pharmaceutical preparations for the diagnosis, prevention and treatment of psychiatric, neurological, hormonal, genetic and endocrine disorders and conditions; pharmaceutical preparations for human use for diagnosis, prevention and treatment of psychiatric, neurological, hormonal, genetic and endocrine diseases and disorders by gene therapy; pharmaceuticals for human use for the treatment of rare and orphan diseases, disorders and conditions of the neurological, hormonal, and endocrine systems; pharmaceutical preparations for the treatment of congenital adrenal hyperplasia |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, October 15, 2021 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Neurocrine Biosciences, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | San Diego, CA 92130 |
| Party Name | Neurocrine Biosciences, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | San Diego, CA 92130 |
| Event Date | Event Description |
| Wednesday, February 28, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, February 27, 2024 | SOU EXTENSION 2 GRANTED |
| Tuesday, February 27, 2024 | SOU EXTENSION 2 FILED |
| Tuesday, February 27, 2024 | SOU TEAS EXTENSION RECEIVED |
| Wednesday, September 13, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Monday, September 11, 2023 | SOU EXTENSION 1 GRANTED |
| Monday, September 11, 2023 | SOU EXTENSION 1 FILED |
| Monday, September 11, 2023 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, March 14, 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, January 17, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, January 17, 2023 | PUBLISHED FOR OPPOSITION |
| Wednesday, December 28, 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Thursday, December 8, 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, December 7, 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, December 6, 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, December 6, 2022 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, June 9, 2022 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, June 9, 2022 | NON-FINAL ACTION E-MAILED |
| Thursday, June 9, 2022 | NON-FINAL ACTION WRITTEN |
| Wednesday, June 8, 2022 | ASSIGNED TO EXAMINER |
| Friday, October 15, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, September 7, 2021 | NEW APPLICATION ENTERED |